NFKB1 and neuromyelitis optica: Using primary astrocytes and mouse models of NMO, we demonstrated that MSC-derived MFGE8 improves the motor deficits in NMO mouse models by inhibiting motor neuron loss and reducing the release of inflammatory factors targeted by NF-κB.